Recent Advances in AIDS and HIV Research

艾滋病和艾滋病毒研究的最新进展

• 批准号: 8705971
• 负责人: PAUL A VOLBERDING
• 金额: $ 1.5万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-09-01 至 2017-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8705971
• 关键词: AIDS/HIV problem; Acquired Immunodeficiency Syndrome; Administrator; Advertising; Area; Award; Biometry; Clinical; Collaborations; Communication; Country; Development; Environment; Ethnic group; Fostering; Funding; Funding Opportunities; Future; HIV; HIV Infections; Individual; Infection; Institutes; Institution; Internet; Investigation; Leadership; Link; Location; Malignant Neoplasms; National Institute of Mental Health; Outcome; Participant; Prevention; Research; Research Personnel; Scholarship; Site; Staging; System; Travel; United States National Institutes of Health; Universities; Vaccines; Viral; Woman; base; behavioral/social science; career; continuing medical education; health disparity; interest; meetings; next generation; posters; preference; programs; research and development; symposium; working group

Description (as provided by the applicant): Since 1998, the NIH-funded Centers for AIDS Research (CFAR) have hosted an annual one day National CFAR Scientific Symposium in conjunction with the annual CFAR Directors'/Administrators' meeting. The purpose of the CFAR scientific symposium is to present, in a public forum, recent "cutting edge" advances in HIV/AIDS research for an average attendance of approximately 250-300. The intimate size of the meeting promotes opportunities for interactions between young and more senior investigators that would not be available at the larger annual scientific meetings related to HIV/AIDS. The meeting location rotates so that it is hosted each year by a different CFAR site. This provides geographic diversity for the venue and opportunities for a broader array of participants than for similar research symposia. As has been done for the past fifteen years, one of several AIDS-related research areas is the focus of the annual symposium. In 2011, the Duke University CFAR hosted the 15th Annual CFAR Research Symposium with focus on five scientific areas: "Host-Viral Interactions during HIV Infection", "HIV-Associated Malignancies and Co-Infections", "Emerging Vaccine Strategies", "HIV/AIDS Health Disparities", and "Approaches to an HIV Cure". Speakers were selected from the various NIH-funded Centers for AIDS Research leadership, their scientific membership, and from nationally and internationally recognized research institutions. In addition to the participating CFAR Directors and invited leaders in the field, the remaining participants for the annual National CFAR Symposia are chosen based on specific criteria. First preference is given to young investigators who have received developmental funds from an NIH-funded CFAR program; second preference to young investigators with demonstrable potential in HIV/AIDS research; third preference is to other senior investigators engaged in HIV/AIDS research. In all cases women and individuals from underrepresented ethnic groups are encouraged to attend through targeted advertising and travel scholarships. Continuing Medical Education credits have been offered for attendees and access to web casts of the symposia are now available for interested investigators who are not able to attend.

描述（如申请人提供）：自1998年以来，NIH资助的艾滋病研究中心（CFAR）与年度CFAR董事/管理员的会议一起举办了一年一度的一年一度的国家CFAR科学研讨会。 CFAR科学研讨会的目的是在公共论坛中提出艾滋病毒/艾滋病研究的最新“最先进”进步，平均出席率约为250-300。会议的私密规模促进了与艾滋病毒/艾滋病有关的较大的年度科学会议，这将促进年轻与更多高级调查员之间互动的机会。会议地点旋转，因此每年由不同的CFAR网站托管。与类似的研究研讨会相比，这为广泛的参与者提供了地理多样性和机会。正如过去15年来所做的那样，与AIDS相关的几个研究领域之一是年度研讨会的重点。 2011年，杜克大学CFAR主持了第15届年度CFAR研究研讨会，重点关注五个科学领域：“艾滋病毒感染期间的宿主病毒相互作用”，“与HIV相关的恶性肿瘤和共同感染”，“新兴的疫苗策略”，“艾滋病毒/艾滋病健康”和“艾滋病健康”以及对HIV cile的方法。从NIH资助的各种艾滋病研究领导，其科学会员资格以及国内和国际认可的研究机构中选出了演讲者。除了参与的CFAR董事和该领域的受邀领导人外，还根据特定标准选择了年度国家CFAR专题讨论会的其余参与者。首先是从NIH资助的CFAR计划中获得发展基金的年轻调查人员；第二个偏爱艾滋病毒/艾滋病研究具有明显潜力的年轻研究者；第三个偏爱是其他从事艾滋病毒/艾滋病研究的高级研究人员。在所有情况下，鼓励来自代表性不足的族裔群体的妇女和个人通过有针对性的广告和旅行奖学金参加。为与会者提供了持续的医学教育学分，现在可以为无法参加的有兴趣的调查人员提供参加研讨会的网络演员。